| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39bf0bb8b07e151d4bcead749d7dd699 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2017-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c48d811cb4d0a212576f8bf27e703c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ea85f85fe35f998d7b9793212b005fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ccf44f3bf289ac02023fe2ed396c2b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_574c65fc70a111278bbef35d3ae76699 |
| publicationDate |
2018-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BE-1024774-B1 |
| titleOfInvention |
COMPOSITIONS AND METHODS OF TREATMENT |
| abstract |
The present invention relates to nucleic acid constructs capable of encoding antigenic peptides or polypeptides from multiple early human papillomavirus (HPV) proteins, and immunogenic compositions comprising such nucleic acid constructs and a pharmaceutically acceptable carrier. These nucleic acid constructs and immunogenic compositions are useful in the treatment of persistent HPV infection and low-grade HPV lesions, particularly infections and lesions of human anogenital epithelial tissue, such as cervical epithelium. . |
| priorityDate |
2016-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |